Literature DB >> 278631

Colony formation in vitro by leukemic cells in acute lymphoblastic leukemia (ALL).

S D Smith, E M Uyeki, J T Lowman.   

Abstract

An assay system in vitro for the growth of malignant lymphoblastic colony-forming cells (CFC) was established. Growth of malignant myeloblastic CFC has been previously reported, but this is the first report of growth of malignant lymphoblastic CFC. Established assay systems in vitro have been very helpful in elucidating the control of growth and differentiation of both normal and malignant bone marrow cells. Lymphoblastic CFC were grown from the bone marrow aspirates of 20 children with acute lymphoblastic leukemia. Growth of these colonies was established on an agar assay system and maintained in the relative hypoxia (7% oxygen) of a Stulberg chamber. The criteria for malignancy of these colonies was based upon cellular cytochemical staining characteristics, the presence of specific cell surface markers, and the ability of these lymphoid cells to grow without the addition of a lymphoid mitogen. With this technique, specific nutritional requirements and drug sensitivities can be established in vitro, and these data may permit tailoring of individual antileukemic therapy.

Entities:  

Mesh:

Year:  1978        PMID: 278631

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentration.

Authors:  Michael A Sheard; Matthew V Ghent; Daniel J Cabral; Joanne C Lee; Vazgen Khankaldyyan; Lingyun Ji; Samuel Q Wu; Min H Kang; Richard Sposto; Shahab Asgharzadeh; C Patrick Reynolds
Journal:  Exp Cell Res       Date:  2015-04-03       Impact factor: 3.905

2.  Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients.

Authors:  F M Uckun; J H Kersey; K J Gajl-Peczalska; N A Heerema; A J Provisor; D Haag; G Gilchrist; C W Song; D C Arthur; J Roloff
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

3.  The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation.

Authors:  Z Chen-Levy; J Nourse; M L Cleary
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

Review 4.  One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a "hypoxic" environment.

Authors:  Elisabetta Rovida; Ilaria Marzi; Maria Grazia Cipolleschi; Persio Dello Sbarba
Journal:  Hypoxia (Auckl)       Date:  2014-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.